May 15 |
Palatin Tech GAAP EPS of -$0.53 misses by $0.03
|
May 15 |
Palatin Reports Third Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update
|
May 14 |
Palatin Tech Q3 2024 Earnings Preview
|
May 9 |
Palatin to Report Third Quarter Fiscal Year 2024 Results; Teleconference and Webcast to be held on May 15, 2024
|
May 2 |
Palatin gets FDA OK to test weight loss therapy with Eli Lilly’s tirzepatide
|
May 2 |
Palatin Announces FDA Clearance of IND Application for the Co-Administration of Bremelanotide with Tirzepatide (GLP-1) for the Treatment of Obesity
|
Apr 30 |
Palatin to Host Virtual KOL Event "Beyond GLPs: The Multiple Roles for Novel Melanocortin Receptor 4 Agonists in Treating Obesity and Weight Loss Maintenance" on May 8, 2024
|
Apr 14 |
10 Micro-Cap Healthcare Stocks Insiders Are Buying
|
Apr 12 |
Palatin Technologies And 2 Other Stocks Under $3 Insiders Are Buying
|
Apr 9 |
Palatin (PTN) Up 15% on Results From Dry Eye Disease Study
|